Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             46 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Accelerated Access to Medicines Pace, Jessica
 2017
 51 2 p. 157-163
 artikel
2 Accelerated Access to Medicines: An Ethical Analysis Pace, Jessica
51 2 p. 157-163
 artikel
3 Accelerated Pathways Work—Now What? A Survey of Payers in the United States Farrimond, Barry
 2017
 51 2 p. 224-231
 artikel
4 Accelerated Pathways Work—Now What? A Survey of Payers in the United States Farrimond, Barry
51 2 p. 224-231
 artikel
5 A Cross-Sectional Study on the Use of, Preference for, and Perceived Reliability of Mass Media for Drug-Related Information Among the General Public in Sarawak Ting, Chuo Yew
 2017
 51 2 p. 212-220
 artikel
6 A Cross-Sectional Study on the Use of, Preference for, and Perceived Reliability of Mass Media for Drug-Related Information Among the General Public in Sarawak Ting, Chuo Yew
51 2 p. 212-220
 artikel
7 A Global Perspective on Compassionate Use and Expanded Access Watson, Tom
 2017
 51 2 p. 143-145
 artikel
8 A Global Perspective on Compassionate Use and Expanded Access Watson, Tom
51 2 p. 143-145
 artikel
9 An Analysis of Japanese Patients Enrolled in Multiregional Clinical Trials in Oncology Hirakawa, Akihiro
 2017
 51 2 p. 207-211
 artikel
10 An Analysis of Japanese Patients Enrolled in Multiregional Clinical Trials in Oncology Hirakawa, Akihiro
51 2 p. 207-211
 artikel
11 Assessing the Quality of Decision Making in the Development and Regulatory Review of Medicines Bujar, Magdalena
 2017
 51 2 p. 250-256
 artikel
12 Assessing the Quality of Decision Making in the Development and Regulatory Review of Medicines: Identifying Biases and Best Practices Bujar, Magdalena
51 2 p. 250-256
 artikel
13 Book Review: Cardiovascular Safety in Drug Development and Therapeutic Use Seltzer, Jonathan H
 2017
 51 2 p. 180
 artikel
14 Book Review: Cardiovascular Safety in Drug Development and Therapeutic Use Seltzer, Jonathan H.
51 2 p. 180
 artikel
15 Challenges With the Development of Biosimilars in Asia for Western Markets Huml, Raymond A.
 2017
 51 2 p. 200-206
 artikel
16 Challenges With the Development of Biosimilars in Asia for Western Markets: An Overview and Suggested Solutions Huml, Raymond A.
51 2 p. 200-206
 artikel
17 Characteristics That May Help in the Identification of Potentially Confusing Proprietary Drug Names Shah, Millie B.
 2017
 51 2 p. 232-236
 artikel
18 Characteristics That May Help in the Identification of Potentially Confusing Proprietary Drug Names Shah, Millie B.
51 2 p. 232-236
 artikel
19 Considerations for Use of Investigational Drugs in Public Health Emergencies Kirchoff, Matthew Carl
 2017
 51 2 p. 146-152
 artikel
20 Considerations for Use of Investigational Drugs in Public Health Emergencies Kirchoff, Matthew Carl
51 2 p. 146-152
 artikel
21 Considerations for Use of Investigational Drugs in Public Health Emergencies Kirchoff, Matthew Carl
51 2 p. 146-152
 artikel
22 Ethical Considerations in Adaptive Design Clinical Trials Laage, Thomas
 2017
 51 2 p. 190-199
 artikel
23 Ethical Considerations in Adaptive Design Clinical Trials Laage, Thomas
51 2 p. 190-199
 artikel
24 Goods and Services Tax on Pharmaceuticals in Malaysia Wong, Zhi Yen
 2017
 51 2 p. 221-223
 artikel
25 Goods and Services Tax on Pharmaceuticals in Malaysia Wong, Zhi Yen
51 2 p. 221-223
 artikel
26 Innovation for Safe and Effective Medical Devices Zippel, Claus
 2017
 51 2 p. 237-245
 artikel
27 Innovation for Safe and Effective Medical Devices: Contributions From Postmarket Surveillance Zippel, Claus
51 2 p. 237-245
 artikel
28 Innovation for Safe and Effective Medical Devices: Contributions From Postmarket Surveillance Zippel, Claus
51 2 p. 237-245
 artikel
29 Introduction to the “Right to Try” Special Section Vulcano, David
 2017
 51 2 p. 142
 artikel
30 Introduction to the “Right to Try” Special Section Vulcano, David
51 2 p. 142
 artikel
31 Overview of FDA’s Expanded Access Program for Investigational Drugs Jarow, Jonathan P.
 2017
 51 2 p. 177-179
 artikel
32 Overview of FDA’s Expanded Access Program for Investigational Drugs Jarow, Jonathan P.
51 2 p. 177-179
 artikel
33 Patient Voice in Rare Disease Drug Development and Endpoints Deal, Linda S.
 2017
 51 2 p. 257-263
 artikel
34 Patient Voice in Rare Disease Drug Development and Endpoints Deal, Linda S.
51 2 p. 257-263
 artikel
35 Preapproval Access and Right-to-Try Initiatives Gertel, Art
 2017
 51 2 p. 164-169
 artikel
36 Preapproval Access and Right-to-Try Initiatives: What Are We Willing to Give Up? Gertel, Art
51 2 p. 164-169
 artikel
37 Reconciling States’ “Right to Try” Legislation and FDA’s Expanded Access Program Shapiro, Robyn S.
 2017
 51 2 p. 153-156
 artikel
38 Reconciling States’ “Right to Try” Legislation and FDA’s Expanded Access Program: Legal Issues Shapiro, Robyn S.
51 2 p. 153-156
 artikel
39 Sample Size Calculations for Combination Drugs of 2 Monotherapies With a Single Approved Dose Level Kang, Seung-Ho
 2017
 51 2 p. 181-189
 artikel
40 Sample Size Calculations for Combination Drugs of 2 Monotherapies With a Single Approved Dose Level: Binary Endpoint Cases Kang, Seung-Ho
51 2 p. 181-189
 artikel
41 Ten-Year Experience for the Center for Drug Evaluation and Research, Part 2 Jarow, Jonathan P.
 2017
 51 2 p. 246-249
 artikel
42 Ten-Year Experience for the Center for Drug Evaluation and Research, Part 2: FDA’s Role in Ensuring Patient Safety Jarow, Jonathan P.
51 2 p. 246-249
 artikel
43 Transitions, Introductions, and a Notable Announcement From the US FDA in December 2016 Turner, J. Rick
 2017
 51 2 p. 140-141
 artikel
44 Transitions, Introductions, and a Notable Announcement From the US FDA in December 2016 Turner, J. Rick
51 2 p. 140-141
 artikel
45 Who Stands to Benefit? Right to Try Law Provisions and Implications Kearns, Lisa
 2017
 51 2 p. 170-176
 artikel
46 Who Stands to Benefit? Right to Try Law Provisions and Implications Kearns, Lisa
51 2 p. 170-176
 artikel
                             46 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland